UroGen Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
CEOElizabeth Barrett
CEOElizabeth Barrett
Employees235
Employees235
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2004
Founded2004
Employees235
Employees235
URGN Key Statistics
Market cap367.02M
Market cap367.02M
Price-Earnings ratio-2.51
Price-Earnings ratio-2.51
Dividend yield—
Dividend yield—
Average volume1.93M
Average volume1.93M
High today$8.05
High today$8.05
Low today$8.05
Low today$8.05
Open price$7.13
Open price$7.13
Volume1.65K
Volume1.65K
52 Week high$20.70
52 Week high$20.70
52 Week low$6.46
52 Week low$6.46
URGN News
Simply Wall St 3d
Lacklustre Performance Is Driving UroGen Pharma Ltd.'s 30% Price DropThe UroGen Pharma Ltd. ( ) share price has fared very poorly over the last month, falling by a substantial 30%. The drop over the last 30 days has capped off a...
TipRanks 4d
UroGen Pharma down after FDA posts UGN-102 briefing documentsShares of Urogen Pharma (URGN) are down $2.62, or 27%, or $7.23 after the FDA confirmed an ODAC meeting for UGN-102 will occur on May 21 and posted the associat...
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.